The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells

Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12–15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Atif, Fahim, Patel, Neil R., Yousuf, Seema, Stein, Donald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482510/
https://www.ncbi.nlm.nih.gov/pubmed/26110872
http://dx.doi.org/10.1371/journal.pone.0131441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482510/
https://www.ncbi.nlm.nih.gov/pubmed/26110872
http://dx.doi.org/10.1371/journal.pone.0131441

Ejemplares similares